PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 19, 2026Scientific Reports0 citationsOpen Access

Dapagliflozin attenuates cisplatin-induced nephrotoxicity in rats through modulation of ROS/NF-κB, BCL2/Bax and PINK1/Parkin signaling pathways

EKEsraa K. KhallafEREman A. RamadanMEMohey M. Elmazar

Key Result

Dapagliflozin prevented cisplatin-induced nephrotoxicity in rats by activating PINK1/Parkin-mediated mitophagy and attenuating oxidative stress and apoptotic activity.

Key Points

  • This study aims to investigate the protective effects of dapagliflozin against cisplatin-induced nephrotoxicity in rats, focusing on several key signaling pathways.
  • Male Sprague Dawley rats received 10 mg/kg of dapagliflozin daily for 14 days.
  • Cisplatin was administered on day 10 to induce acute kidney injury (7 mg/kg, intraperitoneal).
  • Various biomarkers and histological changes were assessed post-treatment.
  • Dapagliflozin reduced glomerular and tubular damage, decreasing NGAL and KIM-1 expression.
  • The treatment mitigated the expression of inflammatory markers such as NF-kB and TNF-α, and improved the BCL2/Bax ratio.
  • Dapagliflozin restored mitophagy markers and reduced cleaved caspase-3, indicating reduced apoptotic activity.

Structured PICO

Does dapagliflozin prevent cisplatin-induced nephrotoxicity in rats?

P
Population
Male Sprague Dawley rats with acute kidney injury induced by a single injection of cisplatin (7 mg/kg; i.p)
I
Intervention
Dapagliflozin 10 mg/kg oral daily for 14 consecutive days
C
Comparator
Cisplatin alone (implied control group)
O
Outcome
Blood glucose, serum levels of creatinine and urea nitrogen, oxidative stress, inflammatory, apoptotic, mitophagy markers, and histological changessurrogate

Dapagliflozin prevents cisplatin-induced nephrotoxicity in a rat model by activating PINK1/Parkin-mediated mitophagy and attenuating oxidative stress and apoptosis.

Abstract

Abstract Dapagliflozin (DPG), an anti-diabetic drug, has gained attention for its renal protective effects through multiple molecular pathways, yet its impact on mitophagy in cisplatin (CIS) nephrotoxicity remains unclear. This study aimed to examine the impact of DPG against CIS-induced nephrotoxicity in rats, targeting mainly PINK1/Parkin-mediated mitophagy and inflammatory/apoptotic pathways. Male Sprague Dawley rats received DPG (10 mg/kg; p.o) daily for 14 consecutive days and AKI was induced by a single injection of CIS (7 mg/kg; i.p) on day 10. Blood glucose, serum levels of creatinine and urea nitrogen, oxidative stress, inflammatory, apoptotic, mitophagy markers, and histological changes were assessed. DPG reduced glomerular and tubular damage by alleviating NGAL and KIM-1 protein expression as well as MDA and NO accompanied by enhanced GSH expression. It mitigated gene expression of NF-κB, TNF-α and IL-6 along with downregulation of Bax and upregulation of BCL2 mRNA expression. DPG prevented apoptotic activity through reduction in cleaved caspase-3 immunoreactivity. Moreover, DPG restored CIS-mediated mitophagy inhibition evidenced by elevation of PINK1, Parkin and LC3II/LC3I ratio and reduction of TIMM23, TOMM20 and p62. In conclusion, DPG prevents CIS nephrotoxicity probably, via activating PINK1/Parkin, meanwhile attenuating oxidative stress and apoptotic activity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Khallaf et al. (2026) studied Cisplatin-induced nephrotoxicity. Dapagliflozin vs. Cisplatin alone was evaluated on Glomerular and tubular damage, oxidative stress, inflammatory, apoptotic, and mitophagy markers. Dapagliflozin prevented cisplatin-induced nephrotoxicity in rats by activating PINK1/Parkin-mediated mitophagy and attenuating oxidative stress and apoptotic activity.

synapsesocial.com/papers/6a0bfdc7166b51b53d3790b6https://doi.org/10.1038/s41598-026-50755-0
Ask AI
Helpful
Bookmark
Share
View Full Paper